Literature DB >> 12895676

Effects of the synthetic cannabinoid nabilone on spatial learning and hippocampal neurotransmission.

Giovanni Diana1, Massimiliano Malloni, Massimo Pieri.   

Abstract

Cannabinoids, the active components of marijuana, affect memory and hippocampal neurotransmission. It has been claimed that nabilone, a synthetic cannabinoid endowed with antiemetic properties, has a peculiar profile of actions. We studied the effects of the drug on spatial learning and in vitro hippocampal CA1 electrophysiology in the rat. Nabilone (0.1, 0.5, and 1.0 mg/kg ip) does not impair place learning in a water maze task, whereas Delta(8)-tetrahydrocannabinol (Delta(8)-THC) disrupts this function. At concentrations ranging from 1 nM to 10 microM nabilone does not influence basal glutamatergic neurotransmission, which is decreased by Delta(8)-THC. Although cannabinoids have been consistently reported to affect synaptic plasticity, nabilone 1 microM does not change paired-pulse facilitation, long-term potentiation and the magnitude of long-term depression. However, the time course of the latter phenomenon is significantly changed by the drug, the depression being lower than in control experiments from 7 to 35 min postinduction. Altogether, our data indicate that there might be differences in the effects of agonists for central cannabinoid receptors, which could help to understand the pharmacology of this class of molecules. The results also suggest that amnesia induced by cannabinoids be possibly related to their effects on hippocampal neurotransmission. The study supports the use of nabilone in conditions the course of which is complicated by cognitive impairment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12895676     DOI: 10.1016/s0091-3057(03)00127-8

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  7 in total

1.  Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor-mediated excitotoxic damage.

Authors:  Basma Shouman; Romain H Fontaine; Olivier Baud; Leslie Schwendimann; Matthias Keller; Michael Spedding; Vincent Lelièvre; Pierre Gressens
Journal:  Br J Pharmacol       Date:  2006-05-08       Impact factor: 8.739

2.  Effects of co-administration of 2-arachidonylglycerol (2-AG) and a selective µ-opioid receptor agonist into the nucleus accumbens on high-fat feeding behaviors in the rat.

Authors:  Kyle E Parker; Jordan G McCall; Sophia R McGuirk; Seema Trivedi; Dennis K Miller; Matthew J Will
Journal:  Brain Res       Date:  2015-06-19       Impact factor: 3.252

3.  Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain : a double-blind placebo-controlled cross-over trial.

Authors:  Jörg Wissel; Tanja Haydn; Jörg Müller; Christian Brenneis; Thomas Berger; Werner Poewe; Ludwig D Schelosky
Journal:  J Neurol       Date:  2006-09-20       Impact factor: 4.849

4.  In Vivo Bio-Activation of JWH-175 to JWH-018: Pharmacodynamic and Pharmacokinetic Studies in Mice.

Authors:  Micaela Tirri; Raffaella Arfè; Sabrine Bilel; Giorgia Corli; Beatrice Marchetti; Anna Fantinati; Fabrizio Vincenzi; Fabio De-Giorgio; Cristian Camuto; Monica Mazzarino; Mario Barbieri; Rosa Maria Gaudio; Katia Varani; Pier Andrea Borea; Francesco Botrè; Matteo Marti
Journal:  Int J Mol Sci       Date:  2022-07-21       Impact factor: 6.208

Review 5.  Cannabinoid and endocannabinoid system: a promising therapeutic intervention for multiple sclerosis.

Authors:  Hina Khan; Fareeha Khalid Ghori; Uzma Ghani; Aneela Javed; Saadia Zahid
Journal:  Mol Biol Rep       Date:  2022-02-18       Impact factor: 2.742

6.  Localization of CB1 cannabinoid receptor mRNA in the brain of the chick (Gallus domesticus).

Authors:  Todd L Stincic; Richard L Hyson
Journal:  Brain Res       Date:  2008-09-20       Impact factor: 3.252

7.  Effects of endocannabinoid system modulation on cognitive and emotional behavior.

Authors:  Claudio Zanettini; Leigh V Panlilio; Mano Alicki; Steven R Goldberg; József Haller; Sevil Yasar
Journal:  Front Behav Neurosci       Date:  2011-09-13       Impact factor: 3.558

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.